We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$79.7M
AUM Growth
-$662M
Cap. Flow
-$660M
Cap. Flow %
-828.28%
Top 10 Hldgs %
21.47%
Holding
303
New
144
Increased
52
Reduced
48
Closed
59

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$1.36M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$1.1M
3
UPW icon
ProShares Ultra Utilities
UPW
+$905K
4
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$786K
5
PBYI icon
Puma Biotechnology
PBYI
+$617K

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners, L.P.
ETP
+$93.5M
2
WPZ
Williams Partners L.P.
WPZ
+$65M
3
BPL
Buckeye Partners, L.P.
BPL
+$48.9M
4
ET icon
Energy Transfer Partners
ET
+$45.2M
5
EPD icon
Enterprise Products Partners
EPD
+$40.2M

Sector Composition

Rank Sector Weight
1 Healthcare 70.8%
2 Financials 1.05%
3 Consumer Discretionary 0.59%
4 Technology 0.58%
5 Consumer Staples 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTEC icon
1
Fidelity MSCI Information Technology Index ETF
FTEC
$20B
$3.5M 4.4%
70,117
+6,700
+11% +$330K
VPU
2
Vanguard Utilities ETF
VPU
$8.62B
$2.69M 3.38%
23,070
-6,200
-21% -$749K
TLT icon
3
iShares 20+ Year Treasury Bond ETF
TLT
$42.5B
$1.99M 2.5%
15,689
+10,800
+221% +$1.36M
VDE icon
4
Vanguard Energy ETF
VDE
$9.84B
$1.9M 2.38%
19,199
+850
+5% +$79.9K
FAS icon
5
Direxion Daily Financial Bull 3x ETF
FAS
$2.4B
$1.6M 2.01%
23,453
+2,950
+14% +$184K
UPW icon
6
ProShares Ultra Utilities
UPW
$17.9M
$1.11M 1.4%
94,800
+71,600
+309% +$905K
EXEL icon
7
Exelixis
EXEL
$14.2B
$1.11M 1.39%
36,522
-16,099
-31% -$428K
ONCE
8
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.09M 1.37%
21,196
+15,378
+264% +$1.1M
NBIX icon
9
Neurocrine Biosciences
NBIX
$17.4B
$1.06M 1.33%
13,652
-9,899
-42% -$675K
UTHR icon
10
United Therapeutics
UTHR
$22.6B
$1.05M 1.32%
7,098
-854
-11% -$109K
RDUS
11
DELISTED
Radius Health, Inc.
RDUS
$1.04M 1.31%
32,863
+7,964
+32% +$250K
VNDA icon
12
Vanda Pharmaceuticals
VNDA
$324M
$1.03M 1.29%
67,813
-6,920
-9% -$103K
ENTA icon
13
Enanta Pharmaceuticals
ENTA
$380M
$1.03M 1.29%
17,531
-14,704
-46% -$736K
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$123B
$1.02M 1.28%
6,818
-1,482
-18% -$219K
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$1.01M 1.27%
14,929
-1,420
-9% -$99.3K
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.01M 1.27%
72,547
+8,058
+12% +$109K
NKTR icon
17
Nektar Therapeutics
NKTR
$2.22B
$1.01M 1.27%
1,126
-2,616
-70% -$1.55M
SRPT icon
18
Sarepta Therapeutics
SRPT
$1.81B
$996K 1.25%
17,897
-13,336
-43% -$706K
TSRO
19
DELISTED
TESARO, Inc.
TSRO
$996K 1.25%
12,023
+4,926
+69% +$483K
ACOR
20
DELISTED
Acorda Therapeutics
ACOR
$991K 1.24%
385
-115
-23% -$327K
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
$990K 1.24%
18,503
+2,315
+14% +$135K
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$989K 1.24%
20,318
+11,378
+127% +$575K
HALO icon
23
Halozyme
HALO
$9.19B
$981K 1.23%
48,401
-29,953
-38% -$551K
LGND icon
24
Ligand Pharmaceuticals
LGND
$6.01B
$981K 1.23%
11,479
-2,863
-20% -$248K
KERX
25
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$980K 1.23%
210,666
+53,601
+34% +$295K
1
2 3 4 5

Similar funds

AMIM
Aull & Monroe Investment Management Mobile, Alabama $215M AUM 28.37% 1-Year Est. Return
EFS
Econ Financial Services Harrisburg, Pennsylvania $215M AUM 6.73% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return

Virtus ETF Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus ETF Advisers held 303 positions worth $79.7M, down 89% from $742M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Virtus ETF Advisers withdrew a net $660M in Q4 2017, closing 59 positions and reducing 48 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $93.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Virtus ETF Advisers opened a new position in iShares MSCI India ETF worth $427K.

  • Virtus ETF Advisers's largest Q4 2017 buy was iShares MSCI India ETF: 11,844 shares worth $427K.
  • Virtus ETF Advisers added most to iShares 20+ Year Treasury Bond ETF in Q4 2017, an estimated $1.36M increase.
  • Virtus ETF Advisers's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $1.55M.
  • Virtus ETF Advisers fully exited Energy Transfer Partners, L.P. in Q4 2017, selling an estimated $93.5M.
  • Virtus ETF Advisers's ten largest holdings make up 21% of its $79.7M portfolio in Q4 2017.
  • Virtus ETF Advisers opened 144 new positions and closed 59 in Q4 2017.
  • Virtus ETF Advisers's portfolio value fell 89% quarter-over-quarter to $79.7M.

Based on Virtus ETF Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.